{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:01:53Z","timestamp":1787666513121,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-024-00803-1","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T15:02:33Z","timestamp":1729782153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vagus nerve stimulation in Parkinson\u2019s disease: a scoping review of animal studies and human subjects research"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-8316","authenticated-orcid":false,"given":"Alexandra","family":"Evancho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"Fortenberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4711-0977","authenticated-orcid":false,"given":"Alibek","family":"Sartayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"803_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon, D. K., Tanner, C. M. & Brundin, P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin. Geriatr. Med. 36, 1 (2020).","journal-title":"Clin. Geriatr. Med."},{"key":"803_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ene.13919","volume":"26","author":"R Durcan","year":"2019","unstructured":"Durcan, R. et al. Prevalence and duration of non-motor symptoms in prodromal Parkinson\u2019s disease. Eur. J. Neurol. 26, 979\u2013985 (2019).","journal-title":"Eur. J. Neurol."},{"key":"803_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"803_CR4","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","volume":"22","author":"RF Pfeiffer","year":"2016","unstructured":"Pfeiffer, R. F. Non-motor symptoms in Parkinson\u2019s disease. Parkinson. Relat. Disord. 22, S119\u2013S122 (2016).","journal-title":"Parkinson. Relat. Disord."},{"key":"803_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cortex.2022.03.009","volume":"151","author":"P Pieperhoff","year":"2022","unstructured":"Pieperhoff, P. et al. Regional changes of brain structure during progression of idiopathic Parkinson\u2019s disease \u2013 A longitudinal study using deformation based morphometry. Cortex 151, 188\u2013210 (2022).","journal-title":"Cortex"},{"key":"803_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/2231-4040.191416","volume":"7","author":"KG Prakash","year":"2016","unstructured":"Prakash, K. G. et al. Neuroanatomical changes in Parkinson\u2019s disease in relation to cognition: An update. J. Adv. Pharm. Technol. Res. 7, 123\u2013126 (2016).","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"803_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk, C. D., Perez-Pardo, P., Garssen, J., van Wezel, R. J. & Kraneveld, A. D. Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front. Neurol. 8, 37 (2017).","journal-title":"Front. Neurol."},{"key":"803_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.25364","volume":"84","author":"AJ Espay","year":"2018","unstructured":"Espay, A. J. et al. Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts. Ann. Neurol. 84, 797\u2013811 (2018).","journal-title":"Ann. Neurol."},{"key":"803_CR9","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1212\/WNL.59.6_suppl_4.S15","volume":"59","author":"SC Schachter","year":"2002","unstructured":"Schachter, S. C. Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 59, S15\u2013S29 (2002).","journal-title":"Neurology"},{"key":"803_CR10","first-page":"17","volume":".","author":"SM Berry","year":"2013","unstructured":"Berry, S. M. et al. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devi. 6, 17\u201335 (2013).","journal-title":"Med Devi"},{"key":"803_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cnr.2004.06.006","volume":"4","author":"MS George","year":"2004","unstructured":"George, M. S. et al. Mechanisms of action of vagus nerve stimulation (VNS). Clin. Neurosci. Res. 4, 71\u201379 (2004).","journal-title":"Clin. Neurosci. Res."},{"key":"803_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12640-018-9889-z","volume":"34","author":"MY Zhu","year":"2018","unstructured":"Zhu, M. Y. Noradrenergic modulation on dopaminergic neurons. Neurotox. Res34, 848\u2013859 (2018).","journal-title":"Neurotox. Res"},{"key":"803_CR13","doi-asserted-by":"publisher","unstructured":"Azman, K. F. & Zakaria, R. Recent advances on the role of Brain-Derived Neurotrophic Factor (BDNF) in neurodegenerative diseases. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23126827 (2022).","DOI":"10.3390\/ijms23126827"},{"key":"803_CR14","doi-asserted-by":"publisher","first-page":"e2023285119","DOI":"10.1073\/pnas.2023285119","volume":"119","author":"AS Caravaca","year":"2022","unstructured":"Caravaca, A. S. et al. Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the \u03b17nAChR subunit. Proc. Natl Acad. Sci. 119, e2023285119 (2022).","journal-title":"Proc. Natl Acad. Sci."},{"key":"803_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"803_CR16","doi-asserted-by":"publisher","first-page":"1155669","DOI":"10.3389\/fneur.2023.1155669","volume":"14","author":"CB Stewart","year":"2023","unstructured":"Stewart, C. B. et al. The longitudinal progression of autonomic dysfunction in Parkinson\u2019s disease: A 7-year study. Front Neurol. 14, 1155669 (2023).","journal-title":"Front Neurol."},{"key":"803_CR17","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","volume":"17","author":"RF Pfeiffer","year":"2020","unstructured":"Pfeiffer, R. F. Autonomic dysfunction in Parkinson\u2019s disease. Neurotherapeutics 17, 1464\u20131479 (2020).","journal-title":"Neurotherapeutics"},{"key":"803_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","volume":"117","author":"H Kaufmann","year":"2013","unstructured":"Kaufmann, H. & Goldstein, D. S. Autonomic dysfunction in Parkinson disease. Handb. Clin. Neurol. 117, 259\u2013278 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"803_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(21)00219-2","volume":"20","author":"Y Sharabi","year":"2021","unstructured":"Sharabi, Y., Vatine, G. D. & Ashkenazi, A. Parkinson\u2019s disease outside the brain: targeting the autonomic nervous system. Lancet Neurol. 20, 868\u2013876 (2021).","journal-title":"Lancet Neurol."},{"key":"803_CR20","first-page":"6","volume":"12","author":"T Ziemssen","year":"2005","unstructured":"Ziemssen, T. & Schmidt, C. Dysautonomia in Parkinson\u2019s disease. Psychopharmakotherapie 12, 6\u201312 (2005).","journal-title":"Psychopharmakotherapie"},{"key":"803_CR21","doi-asserted-by":"publisher","first-page":"102893","DOI":"10.1016\/j.autneu.2021.102893","volume":"236","author":"A Carandina","year":"2021","unstructured":"Carandina, A. et al. Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease. Auton. Neurosci. 236, 102893 (2021).","journal-title":"Auton. Neurosci."},{"key":"803_CR22","doi-asserted-by":"publisher","unstructured":"Ottaviani, M. M., Vallone, F., Micera, S. & Recchia, F. A. Closed-Loop Vagus nerve stimulation for the treatment of cardiovascular diseases: state of the art and future directions. Front. Cardiovasc. Med. 9 https:\/\/doi.org\/10.3389\/fcvm.2022.866957 (2022).","DOI":"10.3389\/fcvm.2022.866957"},{"key":"803_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fnins.2020.00284","volume":"14","author":"JYY Yap","year":"2020","unstructured":"Yap, J. Y. Y. et al. Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci. 14, 284 (2020).","journal-title":"Front Neurosci."},{"key":"803_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.brs.2017.08.008","volume":"10","author":"AQ Farrand","year":"2017","unstructured":"Farrand, A. Q. et al. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson\u2019s disease. Brain Stimul. 10, 1045\u20131054 (2017).","journal-title":"Brain Stimul."},{"key":"803_CR25","doi-asserted-by":"publisher","unstructured":"Farrand, A. Q. et al. Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson\u2019s disease model. Behav. Brain Res. 373 https:\/\/doi.org\/10.1016\/j.bbr.2019.112080 (2019).","DOI":"10.1016\/j.bbr.2019.112080"},{"key":"803_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.brs.2020.06.078","volume":"13","author":"AQ Farrand","year":"2020","unstructured":"Farrand, A. Q. et al. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson\u2019s disease. Brain Stimul. 13, 1323\u20131332 (2020).","journal-title":"Brain Stimul."},{"key":"803_CR27","doi-asserted-by":"publisher","unstructured":"Lench, D. H. et al. Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson\u2019s disease: evaluating feasibility, safety, and preliminary efficacy. Front. Neurol. 14 https:\/\/doi.org\/10.3389\/fneur.2023.1210103 (2023).","DOI":"10.3389\/fneur.2023.1210103"},{"key":"803_CR28","doi-asserted-by":"publisher","unstructured":"Marano, M. et al. Left vagus stimulation modulates contralateral subthalamic \u03b2 power improving the gait in Parkinson\u2019s disease. Movement Disord. https:\/\/doi.org\/10.1002\/mds.29690 (2023).","DOI":"10.1002\/mds.29690"},{"key":"803_CR29","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/mds.27664","volume":"34","author":"R Morris","year":"2019","unstructured":"Morris, R. et al. Noninvasive vagus nerve stimulation to target gait impairment in Parkinson\u2019s disease. Mov. Disord. 34, 918\u2013919 (2019).","journal-title":"Mov. Disord."},{"key":"803_CR30","doi-asserted-by":"publisher","unstructured":"Torrecillos, F. et al. Non-invasive vagus nerve stimulation modulates subthalamic beta activity in Parkinson\u2019s disease. Brain Stimul. https:\/\/doi.org\/10.1016\/j.brs.2022.11.006 (2022).","DOI":"10.1016\/j.brs.2022.11.006"},{"key":"803_CR31","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1111\/cns.14309","volume":"29","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson\u2019s disease: A pilot randomized study. CNS Neurosci. Ther. 29, 3889\u20133900 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"803_CR32","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11064-018-2639-z","volume":"43","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Auricular vagus nerve stimulation exerts antiinflammatory effects and immune regulatory function in a 6-OHDA Model of Parkinson\u2019s disease. Neurochem. Res. 43, 2155\u20132164 (2018).","journal-title":"Neurochem. Res."},{"key":"803_CR33","doi-asserted-by":"publisher","unstructured":"Wang, C. et al. Right vagus nerve stimulation improves motor behavior by exerting neuroprotective effects in Parkinson\u2019s disease rats. Ann. Transl. Med. 10 https:\/\/doi.org\/10.21037\/atm-22-5366 (2022).","DOI":"10.21037\/atm-22-5366"},{"key":"803_CR34","doi-asserted-by":"publisher","unstructured":"Kin, I. et al. Vagus nerve stimulation with mild stimulation intensity exerts anti-inflammatory and neuroprotective effects in Parkinson\u2019s disease model rats. Biomedicines 9 https:\/\/doi.org\/10.3390\/biomedicines9070789 (2021).","DOI":"10.3390\/biomedicines9070789"},{"key":"803_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.brs.2023.03.003","volume":"16","author":"K Hosomoto","year":"2023","unstructured":"Hosomoto, K. et al. Continuous vagus nerve stimulation exerts beneficial effects on rats with experimentally induced Parkinson\u2019s disease: Evidence suggesting involvement of a vagal afferent pathway. Brain Stimul. 16, 594\u2013603 (2023).","journal-title":"Brain Stimul."},{"key":"803_CR36","doi-asserted-by":"publisher","unstructured":"Weise, D. et al. Assessment of brainstem function with auricular branch of vagus nerve stimulation in Parkinson\u2019s disease. PLoS ONE 10 https:\/\/doi.org\/10.1371\/journal.pone.0120786 (2015).","DOI":"10.1371\/journal.pone.0120786"},{"key":"803_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3233\/NRE-192909","volume":"45","author":"O Kaut","year":"2019","unstructured":"Kaut, O., Janocha, L., Weism\u00fcller, T. J. & W\u00fcllner, U. Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson\u2019s disease patients. NeuroRehabilitation 45, 449\u2013451 (2019).","journal-title":"NeuroRehabilitation"},{"key":"803_CR38","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuint.2012.04.018","volume":"61","author":"M Szczerbowska-Boruchowska","year":"2012","unstructured":"Szczerbowska-Boruchowska, M. et al. The influence of electrical stimulation of vagus nerve on elemental composition of dopamine related brain structures in rats. Neurochem. Int. 61, 156\u2013165 (2012).","journal-title":"Neurochem. Int."},{"key":"803_CR39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/mds.29166","volume":"37","author":"M Marano","year":"2022","unstructured":"Marano, M. et al. Transcutaneous auricular vagus stimulation improves gait and reaction time in Parkinson\u2019s disease. Mov. Disord. 37, 2163\u20132164 (2022).","journal-title":"Mov. Disord."},{"key":"803_CR40","doi-asserted-by":"crossref","unstructured":"Mondal, B., Choudhury, S., Simon, B., Baker, M. R. & Kumar, H. Vol. 34 917-918 (John Wiley & Sons, Inc., Hoboken, New Jersey, 2019).","DOI":"10.1002\/mds.27662"},{"key":"803_CR41","doi-asserted-by":"publisher","unstructured":"Jin, W. Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson\u2019s disease. J. Clin. Med. 9 https:\/\/doi.org\/10.3390\/jcm9010257 (2020).","DOI":"10.3390\/jcm9010257"},{"key":"803_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","volume":"10","author":"K Parain","year":"1999","unstructured":"Parain, K. et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson\u2019s disease substantia nigra. Neuroreport 10, 557\u2013561 (1999).","journal-title":"Neuroreport"},{"key":"803_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euroneuro.2017.12.004","volume":"28","author":"OF O\u2019Leary","year":"2018","unstructured":"O\u2019Leary, O. F. et al. The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus. Eur. Neuropsychopharmacol. 28, 307\u2013316 (2018).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"803_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner, S. C., Le, T. & Wang, S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem Biophys. 508, 1\u201312 (2011).","journal-title":"Arch. Biochem Biophys."},{"key":"803_CR45","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/187152712800792758","volume":"11","author":"RB White","year":"2012","unstructured":"White, R. B. & Thomas, M. G. Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson\u2019s disease. CNS Neurol. Disord. Drug Targets 11, 340\u2013349 (2012).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"803_CR46","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00415-021-10877-z","volume":"269","author":"PF Zhang","year":"2022","unstructured":"Zhang, P. F. & Gao, F. Neuroinflammation in Parkinson\u2019s disease: a meta-analysis of PET imaging studies. J. Neurol. 269, 2304\u20132314 (2022).","journal-title":"J. Neurol."},{"key":"803_CR47","unstructured":"gammaCore, https:\/\/www.gammacore.com\/."},{"key":"803_CR48","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor, M. M. & Nelson, A. B. Circuit mechanisms of Parkinson\u2019s disease. Neuron 101, 1042\u20131056 (2019).","journal-title":"Neuron"},{"key":"803_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13760-016-0739-6","volume":"117","author":"S Tomic","year":"2017","unstructured":"Tomic, S., Rajkovaca, I., Pekic, V., Salha, T. & Misevic, S. Impact of autonomic dysfunctions on the quality of life in Parkinson\u2019s disease patients. Acta Neurol. Belg. 117, 207\u2013211 (2017).","journal-title":"Acta Neurol. Belg."},{"key":"803_CR50","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.apmr.2015.12.020","volume":"97","author":"H Kanegusuku","year":"2016","unstructured":"Kanegusuku, H. et al. Blunted maximal and submaximal responses to cardiopulmonary exercise tests in patients with Parkinson disease. Arch. Phys. Med Rehabil. 97, 720\u2013725 (2016).","journal-title":"Arch. Phys. Med Rehabil."},{"key":"803_CR51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCHEARTFAILURE.109.873968","volume":"2","author":"YH Zhang","year":"2009","unstructured":"Zhang, Y. H. et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a Canine high-rate pacing model. Circ.-Heart Fail. 2, 692\u2013699 (2009).","journal-title":"Circ.-Heart Fail."},{"key":"803_CR52","doi-asserted-by":"publisher","unstructured":"Bishnoi, A., Holtzer, R. & Hernandez, M. E. Brain activation changes while walking in adults with and without neurological disease: systematic review and meta-analysis of functional near-infrared spectroscopy studies. Brain Sci. 11 https:\/\/doi.org\/10.3390\/brainsci11030291 (2021).","DOI":"10.3390\/brainsci11030291"},{"key":"803_CR53","doi-asserted-by":"publisher","first-page":"1151218","DOI":"10.3389\/fnhum.2023.1151218","volume":"17","author":"A Evancho","year":"2023","unstructured":"Evancho, A., Tyler, W. J. & McGregor, K. A review of combined neuromodulation and physical therapy interventions for enhanced neurorehabilitation. Front Hum. Neurosci. 17, 1151218 (2023).","journal-title":"Front Hum. Neurosci."},{"key":"803_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/17434440.2021.1969913","volume":"18","author":"HP Sigurdsson","year":"2021","unstructured":"Sigurdsson, H. P. et al. Noninvasive vagus nerve stimulation in Parkinson\u2019s disease: current status and future prospects. Expert Rev. Med. Devices 18, 971\u2013984 (2021).","journal-title":"Expert Rev. Med. Devices"},{"key":"803_CR55","first-page":"658083","volume":"2011","author":"JA Potashkin","year":"2010","unstructured":"Potashkin, J. A., Blume, S. R. & Runkle, N. K. Limitations of animal models of Parkinson\u2019s disease. Parkinson Dis. 2011, 658083 (2010).","journal-title":"Parkinson Dis."},{"key":"803_CR56","first-page":"54","volume":"3","author":"JP O\u2019Reardon","year":"2006","unstructured":"O\u2019Reardon, J. P., Cristancho, P. & Peshek, A. D. Vagus Nerve Stimulation (VNS) and Treatment of Depression: To the Brainstem and Beyond. Psychiatry 3, 54\u201363 (2006).","journal-title":"Psychiatry"},{"key":"803_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2012","unstructured":"Aarsland, D., P\u00e5hlhagen, S., Ballard, C. G., Ehrt, U. & Svenningsson, P. Depression in Parkinson disease\u2014epidemiology, mechanisms and management. Nat. Rev. Neurol. 8, 35\u201347 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"803_CR58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/mds.27018","volume":"32","author":"EK St Louis","year":"2017","unstructured":"St Louis, E. K., Boeve, A. R. & Boeve, B. F. REM sleep behavior disorder in Parkinson\u2019s disease and other Synucleinopathies. Mov. Disord. 32, 645\u2013658 (2017).","journal-title":"Mov. Disord."},{"key":"803_CR59","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature04767","volume":"441","author":"J Lu","year":"2006","unstructured":"Lu, J., Sherman, D., Devor, M. & Saper, C. B. A putative flip-flop switch for control of REM sleep. Nature 441, 589\u2013594 (2006).","journal-title":"Nature"},{"key":"803_CR60","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve, B. F. et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130, 2770\u20132788 (2007).","journal-title":"Brain"},{"key":"803_CR61","doi-asserted-by":"publisher","unstructured":"Degirmenci, Y., Angelopoulou, E., Georgakopoulou, V. E. & Bougea, A. Cognitive impairment in Parkinson\u2019s disease: an updated overview focusing on emerging pharmaceutical treatment approaches. Medicina 59 https:\/\/doi.org\/10.3390\/medicina59101756 (2023).","DOI":"10.3390\/medicina59101756"},{"key":"803_CR62","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1523\/JNEUROSCI.2759-18.2019","volume":"39","author":"TH Sanders","year":"2019","unstructured":"Sanders, T. H. et al. Cognition-enhancing vagus nerve stimulation alters the epigenetic landscape. J. Neurosci. 39, 3454\u20133469 (2019).","journal-title":"J. Neurosci."},{"key":"803_CR63","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox, S. H. et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov. Disord. 33, 1248\u20131266 (2018).","journal-title":"Mov. Disord."},{"key":"803_CR64","first-page":"586378","volume":"2015","author":"K Dashtipour","year":"2015","unstructured":"Dashtipour, K. et al. Effect of exercise on motor and nonmotor symptoms of Parkinson\u2019s disease. Parkinsons Dis. 2015, 586378 (2015).","journal-title":"Parkinsons Dis."},{"key":"803_CR65","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/271761a0","volume":"271","author":"JD Pettigrew","year":"1978","unstructured":"Pettigrew, J. D. & Kasamatsu, T. Local perfusion of noradrenaline maintains visual cortical plasticity. Nature 271, 761\u2013763 (1978).","journal-title":"Nature"},{"key":"803_CR66","first-page":"147","volume":"61","author":"L D\u00e9t\u00e1ri","year":"1983","unstructured":"D\u00e9t\u00e1ri, L., Juh\u00e1sz, G. & Kukorelli, T. Effect of stimulation of vagal and radial nerves on neuronal activity in the basal forebrain area of anaesthetized cats. Acta Physiol. Hung. 61, 147\u2013154 (1983).","journal-title":"Acta Physiol. Hung."},{"key":"803_CR67","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1212\/WNL.59.6_suppl_4.S3","volume":"59","author":"TR Henry","year":"2002","unstructured":"Henry, T. R. Therapeutic mechanisms of vagus nerve stimulation. Neurology 59, S3\u2013S14 (2002).","journal-title":"Neurology"},{"key":"803_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1037\/0735-7044.118.1.79","volume":"118","author":"D Hassert","year":"2004","unstructured":"Hassert, D., Miyashita, T. & Williams, C. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav. Neurosci. 118, 79 (2004).","journal-title":"Behav. Neurosci."},{"key":"803_CR69","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1124\/jpet.106.104166","volume":"318","author":"AE Dorr","year":"2006","unstructured":"Dorr, A. E. & Debonnel, G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 318, 890\u2013898 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"803_CR70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brs.2015.08.018","volume":"9","author":"M Borland","year":"2016","unstructured":"Borland, M. et al. Cortical map plasticity as a function of vagus nerve stimulation intensity. Brain Stimul. 9, 117\u2013123 (2016).","journal-title":"Brain Stimul."},{"key":"803_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature09656","volume":"470","author":"ND Engineer","year":"2011","unstructured":"Engineer, N. D. et al. Reversing pathological neural activity using targeted plasticity. Nature 470, 101\u2013104 (2011).","journal-title":"Nature"},{"key":"803_CR72","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1093\/cercor\/bhr316","volume":"22","author":"BA Porter","year":"2012","unstructured":"Porter, B. A. et al. Repeatedly pairing vagus nerve stimulation with a movement reorganizes primary motor cortex. Cereb. Cortex 22, 2365\u20132374 (2012).","journal-title":"Cereb. Cortex"},{"key":"803_CR73","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1161\/STROKEAHA.114.006654","volume":"45","author":"SA Hays","year":"2014","unstructured":"Hays, S. A. et al. Vagus nerve stimulation during rehabilitative training improves functional recovery after intracerebral hemorrhage. Stroke 45, 3097\u20133100 (2014).","journal-title":"Stroke"},{"key":"803_CR74","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1545968314521006","volume":"28","author":"N Khodaparast","year":"2014","unstructured":"Khodaparast, N. et al. Vagus nerve stimulation delivered during motor rehabilitation improves recovery in a rat model of stroke. Neurorehabil. Neural Repair 28, 698\u2013706 (2014).","journal-title":"Neurorehabil. Neural Repair"},{"key":"803_CR75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.nbd.2013.08.002","volume":"60","author":"N Khodaparast","year":"2013","unstructured":"Khodaparast, N. et al. Vagus nerve stimulation during rehabilitative training improves forelimb strength following ischemic stroke. Neurobiol. Dis. 60, 80\u201388 (2013).","journal-title":"Neurobiol. Dis."},{"key":"803_CR76","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/1545968315616494","volume":"30","author":"N Khodaparast","year":"2016","unstructured":"Khodaparast, N. et al. Vagus nerve stimulation during rehabilitative training improves forelimb recovery after chronic ischemic stroke in rats. Neurorehabil. Neural Repair 30, 676\u2013684 (2016).","journal-title":"Neurorehabil. Neural Repair"},{"key":"803_CR77","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/neu.2015.3972","volume":"33","author":"DT Pruitt","year":"2016","unstructured":"Pruitt, D. T. et al. Vagus nerve stimulation delivered with motor training enhances recovery of function after traumatic brain injury. J. Neurotrauma 33, 871\u2013879 (2016).","journal-title":"J. Neurotrauma"},{"key":"803_CR78","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(21)00475-X","volume":"397","author":"J Dawson","year":"2021","unstructured":"Dawson, J. et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet 397, 1545\u20131553 (2021).","journal-title":"Lancet"},{"key":"803_CR79","doi-asserted-by":"publisher","first-page":"e34844","DOI":"10.1371\/journal.pone.0034844","volume":"7","author":"H Furmaga","year":"2012","unstructured":"Furmaga, H., Carreno, F. R. & Frazer, A. Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One 7, e34844 (2012).","journal-title":"PLoS One"},{"key":"803_CR80","doi-asserted-by":"publisher","first-page":"523","DOI":"10.14336\/AD.2017.0717","volume":"9","author":"T Shen","year":"2018","unstructured":"Shen, T. et al. BDNF polymorphism: a review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis. 9, 523\u2013536 (2018).","journal-title":"Aging Dis."},{"key":"803_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey, H. & O\u2019Malley, L. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. 8, 19\u201332 (2005).","journal-title":"Int. J. Soc. Res. Methodol."},{"key":"803_CR82","doi-asserted-by":"publisher","unstructured":"Aromataris, E., Lockwood, C., Porritt, K., Pilla, B. & Jordan, Z. (eds). JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-24-01.","DOI":"10.46658\/JBIMES-24-01"},{"key":"803_CR83","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco, A. C. et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Ann. Intern. Med. 169, 467\u2013473 (2018).","journal-title":"Ann. Intern. Med."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00803-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:33:33Z","timestamp":1729787613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1038\/s41531-024-00803-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WJT is a co-founder of a medical device company and an inventor and co-inventor on neuromodulation methods and devices for treating various disorders. All other authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}